30_day FRN

13210

Federal Register / Vol. 74, No. 57 / Thursday, March 26, 2009 / Notices

Officer) P.O. Box 442, St. Louis,
Missouri 63166–2034:
1. Jerry W. Fuller, individually and
acting in concert with Terry R. Fuller
and Mary S. Fuller, all as co–executors
of the estate of Ray C. Fuller; all of
Poplar Grove, Arkansas, to acquire
control of Helena Bancshares, Inc., and
thereby indirectly acquire control of
Helena National Bank, both of Helena,
Arkansas.
Board of Governors of the Federal Reserve
System, March 23, 2009.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E9–6765 Filed 3–25–09; 8:45 am]

requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Sexually Transmitted Disease (STD)
Morbidity Surveillance—New—
National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description

BILLING CODE 6210–01–S

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day-09–08AX]

Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these

The CDC is responsible for the
reporting and dissemination of
nationally notifiable STD morbidity
information for prevention and control
purposes in collaboration with state and
local health departments. Recent
changes in sexually transmitted disease
(STD) epidemiology in the United States
indicate that the existing passive
surveillance for STD does not include
all the elements needed in order to
control and prevent STDs in the U.S.
Towards that end, CDC is proposing a
new electronic information collection
called STD Morbidity Surveillance that
will include information on laboratory
confirmation of syphilis infection and
risk behaviors of persons infected with

syphilis and other STDs. Physicians and
other providers collect demographic,
risk, and clinical (including laboratory)
information from persons diagnosed
with notifiable STDs during a clinical
encounter or counseling session. The
respondents will submit the information
electronically, to the state and local
public health departments. Clinical
specimens obtained from case-patients
are submitted to private or public
diagnostic laboratories with laboratory
requisition forms which includes
information on the provider and casepatient. A subset of the information
reported to state health departments
from health care providers or
laboratories is reported electronically as
a case report e-record to CDC’s
Nationally Notifiable Disease
Surveillance System on a weekly basis.
CDC estimates that 57 respondents
spend 20 minutes each week extracting
notifiable STD surveillance information
from their electronic information
system. CDC staff review STD morbidity
data at varying frequencies to identify
population subgroups at increased risk
for STDs. The target evidence-based
intervention strategies, evaluate the
impact of ongoing control efforts, thus
enhancing our understanding of STD
transmission. There is no cost to
respondents other than their time. The
total estimated annual burden hours are
989.

ESTIMATED ANNUALIZED BURDEN HOURS
Types of
respondent

Form
name

State Health Departments ..............................
Territorial Health Agencies .............................
City and county health departments ...............

Electronic STD Case report ...........................
Electronic STD Case report ...........................
Electronic STD Case report ...........................

Dated: March 19, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–6631 Filed 3–25–09; 8:45 am]

No. of
respondents

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0134]

BILLING CODE 4163–18–P

Center for Biologics Evaluation and
Research eSubmitter Pilot Evaluation
Program for Source Plasma
Establishments
AGENCY:

Food and Drug Administration,

HHS.
ACTION:

Notice.

SUMMARY: The Food and Drug
Administration’s (FDA’s) Center for
Biologics Evaluation and Research
(CBER) is announcing an invitation to
participate in a pilot evaluation program

VerDate Nov<24>2008

20:28 Mar 25, 2009

Jkt 217001

PO 00000

Frm 00038

Fmt 4703

Sfmt 4703

No. of
responses per
respondent

50
5
2

52
2
52

Average
burden per
response
(in hours)
20/60
20/60
20/60

for CBER’s eSubmitter Program
(eSubmitter). CBER’s eSubmitter has
been customized as an automated
biologics license application (BLA) and
BLA supplement (BLS) submission
system for blood and blood components.
Participation in the pilot program is
open to blood establishments that
collect Source Plasma. The pilot
program is intended to provide industry
and CBER regulatory review staff the
opportunity to evaluate the eSubmitter
system and determine if it facilitates the
BLA/BLS submission process. The
purpose of this notice is to invite blood
establishments that collect Source
Plasma to submit a request to CBER if
they are interested in participating in
this pilot program.

E:\FR\FM\26MRN1.SGM

26MRN1